Biocon Ltd
NSE:BIOCON
Biocon Ltd
Cash from Investing Activities
Biocon Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biocon Ltd
NSE:BIOCON
|
Cash from Investing Activities
-₹136B
|
CAGR 3-Years
-95%
|
CAGR 5-Years
-222%
|
CAGR 10-Years
-45%
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Cash from Investing Activities
₹4.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Transgene Biotek Ltd
BSE:526139
|
Cash from Investing Activities
-₹123k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Cash from Investing Activities
-₹72.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Cash from Investing Activities
-₹770m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Cash from Investing Activities
₹4.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
See Also
What is Biocon Ltd's Cash from Investing Activities?
Cash from Investing Activities
-136B
INR
Based on the financial report for Dec 31, 2023, Biocon Ltd's Cash from Investing Activities amounts to -136B INR.
What is Biocon Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-45%
Over the last year, the Cash from Investing Activities growth was -408%. The average annual Cash from Investing Activities growth rates for Biocon Ltd have been -95% over the past three years , -222% over the past five years , and -45% over the past ten years .